Lawsuit on Behalf of Investors in BioScrip Inc (BIOS)

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Lawsuit on Behalf of Investors in BioScrip Inc (BIOS) Announced by Shareholders Foundation

SAN DIEGO, Oct. 7, 2013 (GLOBE NEWSWIRE) -- The Shareholders Foundation, Inc. announces that a lawsuit was filed on behalf of certain purchasers of BioScrip Inc (BIOS) common stock over alleged violations of Federal Securities Laws by BioScrip Inc in connection with certain allegedly false and misleading statements made between August 8, 2011 and September 20, 2013.

Investors who purchased shares of BioScrip Inc (BIOS) have certain options and should contact the Shareholders Foundation at mail(at)shareholdersfoundation.com or call +1(858) 779 - 1554.

The plaintiff alleges that the defendants made allegedly false and/or misleading statements and/or allegedly failed to disclose that BioScrip Inc improperly distributed the product Exjade through its specialty pharmacy operations, that BioScrip Inc was in violation of certain federal and state laws and regulations, and that as a result of the foregoing BioScrip's statements were materially false and misleading at all relevant times.

On September 23, 2013, BioScrip Inc disclosed that it received a civil investigative demand issued by the United States Attorney's Office for the Southern District of New York and a subpoena from the New York State Attorney General's Medicaid Fraud Control Unit, regarding the distribution of the Novartis Pharmaceuticals Corporation product Exjade(R) by the Company's legacy specialty pharmacy division.

Shares of BioScrip Inc declined from $11.72 per share on Sept. 20, 2013, to $8.31 per share on Sept. 25 2013.

The plaintiff seeks to recover damages on behalf of all purchasers of BioScrip Inc common stock between August 8, 2011 and September 20, 2013.

Those who purchased shares of BioScrip Inc (BIOS) have certain options and should contact the Shareholders Foundation, Inc. by e-mail at mail@shareholdersfoundation.com or call +1 (858) 779-1554.

The Shareholders Foundation, Inc. is a professional portfolio legal monitoring and settlement claim filing service, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. The Shareholders Foundation, Inc. is not a law firm. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

Shareholders Foundation, Inc. Trevor Allen +1 (858) 779-1554 3111 Camino Del Rio North Suite 423 San Diego, CA 92108

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Empowering SRPT Shareholders to Take Legal Action with DJS Law Group

Updated Category News Views 129

Empowering SRPT Shareholders to Take Legal Action In the financial landscape, shareholders of Sarepta Therapeutics, Inc. (NASDAQ: SRPT) have a significant opportunity to advocate for their rights through a class action lawsuit initiated by DJS Law Group. The firm is dedicated to representing investors who believe they have been misled regarding the safety and revenue...

Continue Reading
Foresight Group's Strategic Share Buyback Program Insights

Updated Category News Views 142

Understanding Foresight Group's Share Buyback Program The global investment landscape is constantly evolving, and Foresight Group Holdings Limited, renowned for their expertise in real assets and growth capital, has recently made headlines with its share buyback initiative. This strategic move not only reflects the company's confidence in its future but also highlights...

Continue Reading
IceCure Medical's ProSense® Shows Promising Effectiveness in Oncology

Updated Category News Views 69

ProSense® Cryoablation Technology: A Remarkable Advancement in Tumor Treatment IceCure Medical Ltd. is drawing significant attention with its ProSense® system, an innovative cryoablation technology that provides a more effective and less invasive option for treating tumors. This technique utilizes liquid nitrogen, which is proven to be both safer and more economical...

Continue Reading
Mangoceuticals Raises Capital Through Equity Sale and Growth Moves

Updated Category News Views 192

Mangoceuticals Secures Capital Through Equity Offering Mangoceuticals, Inc. (NASDAQ:MGRX), a health services company, recently disclosed a strategic maneuver to enhance its capital. The company sold 33,333 shares of common stock to Platinum Point Capital, garnering net proceeds of $78,787. This is a notable step in their ongoing efforts to finance operations and implement...

Continue Reading
Marksman Titan Security Group Expands with New Acquisition

Updated Category News Views 245

Marksman Titan Security Group Acquires Priebe Security Services Marksman Security Services, LLC, part of the Marksman Titan Security Group, has recently made headlines with its acquisition of Priebe Security Services, a notable security provider in Central Texas. This strategic move not only enhances the company's footprint in the region but also brings together two...

Continue Reading